[1] Mokdad AA,Lopez AD,Shahraz S,et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med,2014,12(1):145. [2] Wang X,Lin SX,Tao J,et al. Study of liver cirrhosis over ten consecutive years in Southern China.World J Gastroenterol,2014,20(37):13546-13555. [3] Bao X, Xu B, Fang K, et al. Changing trends of hospitalisation of liver cirrhosis in Beijing, China. BMJ Open Gastroenterol,2015,2(1): e000051. [4] Conn HO. Spontaneous peritonitis and bacteremia in Laennecfs cirrhosis caused by enteric organisms:A relatively common but rarely recognized syndrome. Ann Intern Med,1964,60:568-580. [5] Soriano G,Castellote J,Alvarez C,et al. Secondary bacterial peritonitis in cirrhosis: A retrospective study of clinical and analytical characteristics, diagnosis and management. J Hepatol, 2010, 52(1) : 39-44. [6] Arvaniti V, Damico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology,2010,139(4):1246-56. [7] Alexopoulou A,Vasilieva L, Agiasotelli D,et al. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol,2016,22(15):4049-4056. [8] Wang Z,Sun R,Wang G,et al.SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury.Redox Biol,2020,28:101343. [9] Liu X,Liang F,Song W,et al.Effect of Nrf2 signaling pathway on the improvement of intestinal epithelial barrier dysfunction by hyperbaric oxygen treatment after spinal cord injury.Cell Stress Chaperones,2021,26(2):433-441. [10] Cahenzli J,Koller Y,Wyss M,et al. Intestinal microbial diversity during early-life colonization shapes long-term IgE levels.Cell Host Microbe,2013,14( 5) : 559-570. [11] Tanouev T,Morita S,Plichta DR,et al.A defined commensal con- sortium elicits CD8 T cells and anti-cancer immunity.Nature,2019,565(7741):600-605. [12] Liu X,Chen Y,You B,et al.Molecular mechanism mediating enteric bacterial translocation after severe burn:The role of cystic fibrosis transmembrane conductance regulator.Burns Trauma,2021,8:42. [13] 梅毅,张茹,彭贺新,等.肝硬化合并自发性细菌性腹膜炎患者免疫因子Th17/Treg失衡的作用机制研究.血栓与止血学,2015,21(5):307-309. [14] Campbell KA,Trivedi HD,Chopra S. Infections in cirrhosis: a guide for the clinician. Am J Med, 2021, 134(6) : 727-734. [15] 高方博,白朝辉,林苏,等. 《2020年英国胃肠病学会与英国肝病学会指南:肝硬化腹水管理》摘译.临床肝胆病杂志,2021,37(2):302-303. [16]中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南.实用肝脏病杂志,2018,21(1):21-31. [17] 彭官清,凌乔,潘沛沛,等.肝硬化并发自发性细菌性腹膜炎患者血清中颗粒蛋白前体水平及临床意义.中华医院感染学杂志,2019,29(23):3558-3562. [18] 李杰,张莉. sTREM-1含量、血降钙素原和C-反应蛋白在肝硬化腹水非多形核细胞性自发性细菌性腹膜炎的诊断意义.中国中西医结合消化杂志,2019,27(6):456-460. [19] Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial. Hepatology,2016,63(4):1299-309. [20] Merli M, Lucidi C, Di GV, et al. An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial. Hepatology,2016,63(5):1632-1639. [21] Qin N,Yang F,Li A,et al. Alterations of the human gut microbiome in liver cirrhosis. Nature,2014,513( 7516) :59-64. [22] Alexopoulou A, Agiasotelli D, Vasilieva LE, et al. Bacterial translocation markers in liver cirrhosis. Ann Gastroenterol,2017,30(5):486-497. [23] Wong CB, Sugahara H, Odamaki T, et al. Different physiological properties of human-residential and non-human-residential bifidobacteria in human health. Benef Microbes,2018,29;9(1):111-122. [24] 梁栋,边绪强,张鼎.腹腔置管灌洗联合腹腔注射抗生素治疗肝硬化自发性腹膜炎的临床研究.肝脏,2021,26(1):37-40. [25] Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol,2013,11(2):123-30. [26] 张囡囡,徐雷,刘鹏.参苓白术颗粒对自发性腹膜炎的治疗作用.中国中医急症,2015,24(12):2252-2254. [27] Fernandez J, Tandon P, Mensa J, et al. Antibiotic prophylaxis in cirrhosis: Good and bad. Hepatology,2016,63(6): 2019-2031. [28] Elfert A, Abo AL, Soliman S, et al. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol,2016,28(12):1450-1454. [29] Gong ZY, Yuan ZQ, Dong ZW, et al. Glutamine with probiotics attenuates intestinal inflammation and oxidative stress in a rat burn injury model through altered iNOS gene aberrant methylation. Am J Transl Res,2017,9(5):2535-2547. |